ChiCTR2200061725 版本V1.0 版本创建时间2022/07/01 17:29:30 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200061725 

最近更新日期:

Date of Last Refreshed on:

2022-07-01 17:29:18 

注册时间:

Date of Registration:

2022-07-01 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

剪切波弹性模量值的改变与急性肾损伤的相关性:一项前瞻性观察性初步研究

Public title:

Alteration in shear wave elastography is associated with acute kidney injury: A prospective observational pilot study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

剪切波弹性模量值的改变与急性肾损伤的相关性:一项前瞻性观察性初步研究

Scientific title:

Alteration in shear wave elastography is associated with acute kidney injury: A prospective observational pilot study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

徐前程 

研究负责人:

徐前程 

Applicant:

Xu Qiancheng 

Study leader:

Xu Qiancheng 

申请注册联系人电话:

Applicant telephone:

18297529106

研究负责人电话:

Study leader's
telephone:

18297529106

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

xu871011@126.com

研究负责人电子邮件:

Study leader's E-mail:

xu871011@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

武汉市武昌区东湖路169号武汉大学中南医院

研究负责人通讯地址:

武汉市武昌区东湖路169号武汉大学中南医院

Applicant address:

Zhongnan Hospital of Wuhan University,Donghu Road, No.167

Study leader's address:

Zhongnan Hospital of Wuhan University,Donghu Road, No.167

申请注册联系人邮政编码:

Applicant postcode:

430071

研究负责人邮政编码:

Study leader's postcode:

430071

申请人所在单位:

武汉大学中南医院

Applicant's institution:

Zhongnan Hospital of Wuhan University

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

202112

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

芜湖市第二人民医院伦理委员会

Name of the ethic committee:

Ethics Committee of the Second People's Hospital of Wuhu

伦理委员会批准日期:

Date of approved by ethic committee:

2021-04-19 00:00:00

伦理委员会联系人:

孙礼侠

Contact Name of the ethic committee:

Sun Lixia

伦理委员会联系地址:

安徽省芜湖市九华中路259号

Contact Address of the ethic committee:

259 Jiuhua Road, Wuhu City, Anhui Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

华东师范大学附属芜湖医院(芜湖市第二人民医院)

Primary sponsor:

Wuhu hospital, EastChina Normal University

研究实施负责(组长)单位地址:

安徽省芜湖市九华中路259号

Primary sponsor's address:

259 Jiuhua Road, Wuhu City, Anhui Province, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

安徽省

市(区县):

芜湖市

Country:

China

Province:

Anhui

City:

Wuhu

单位(医院):

华东师范大学附属芜湖医院(芜湖市第二人民医院)

具体地址:

安徽省芜湖市九华中路259号

Institution
hospital:

Wuhu hospital, EastChina Normal University

Address:

259 Jiuhua Road, Wuhu, Anhui, China

经费或物资来源:

安徽省医疗卫生重点专科建设项目(2021-273)

Source(s) of funding:

Key Medical and Health Specialty Construction project of Anhui Province (2021-273)

研究疾病:

急性肾损伤  

Target disease:

acute kidney injury

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

(1)在重症患者中评价剪切波弹性成像技术测量肾脏皮质弹性模量值的可行性、重复性和一致性; (2)评价肾脏皮质弹性模量值与AKI的相关性。  

Objectives of Study:

(1) To evaluate the feasibility, reliability, and repeatability of shear wave elastography in measuring renal cortical shear modulus in critically ill patients (2) To evaluate the correlation between the value of renal cortex shear modulus and AKI.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

第一部分和第二部分研究
(1) 入住ICU的重症患者
(2) APACHE II评分≥8分;
(3) 签署知情同意书。

Inclusion criteria

Part I and Part II Research
(1) Critically ill patients admitted to ICU
(2) APACHE II score ≥8 points;
(3) Sign the informed consent form.

排除标准:

第一部分研究
(1)年龄<18岁
(2)孕妇
(3)既往存在任何慢性肾脏疾病病史
(4)由肾后阻塞引起的AKI
(5)因患者个体因素或体位限制不能进行超声检查的患者
(6)BMI >30 kg/m2
(7)肾脏深度>8cm
(8)传统肾脏超声检查显示肾脏结构异常
第二部分研究
(1)年龄<18岁
(2)孕妇
(3)既往存在任何慢性肾脏疾病病史
(4)由肾后阻塞引起的AKI
(5)因患者个体因素或体位限制不能进行超声检查的患者
(6)BMI >30 kg/m2
(7)肾脏深度>8cm
(8)传统肾脏超声检查显示肾脏结构异常
(9)平均动脉压<65mmHg或>100mmHg,或去甲肾上腺素或肾上腺素使用量>1ug/kg.min
(10)腹内压明显升高(≥12mmHg)

Exclusion criteria:

Part I Research
(1) Age <18 years old
(2) Pregnant women
(3) Any previous history of chronic kidney disease
(4) AKI caused by obstructive factors
(5) Patients who cannot undergo ultrasonography due to individual patient factors or body position constraints
(6) BMI >30 kg/m2
(7) Those with a renal cortex to skin surface depth of more than 8 cm
(8) And structurally normal kidneys on traditional renal ultrasound

Part II Research
(1) Age <18 years old
(2) Pregnant women
(3) Any previous history of chronic kidney disease
(4) AKI caused by obstructive factors
(5) Patients who cannot undergo ultrasonography due to individual patient factors or body position constraints
(6) BMI >30 kg/m2
(7) Those with a renal cortex to skin surface depth of more than 8 cm
(8) And structurally normal kidneys on traditional renal ultrasound
(9) Mean arterial pressure <65mmHg or >100mmHg,or norepinephrine or epinephrine usage > 1ug/kg.min
(10) Internal pressure increase significantly (≥12mmHg)

研究实施时间:

Study execute time:

From 2021-05-01 00:00:00 To 2022-10-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-05-01 00:00:00 To 2021-09-30 00:00:00

干预措施:

Interventions:

组别:

一致性检验组

样本量:

22

Group:

consistency check group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

相关性研究组

样本量:

54

Group:

Correlation study group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

安徽省 

市(区县):

芜湖市 

Country:

China

Province:

Anhui

City:

Wuhu

单位(医院):

华东师范大学附属芜湖医院(芜湖市第二人民医院 

单位级别:

三级甲等医院 

Institution
hospital:

Wuhu hospital, EastChina Normal University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

上极皮质剪切模量值

指标类型:

主要指标

Outcome:

Upper pole cortex shear modulus

Type:

Primary indicator

测量时间点:

入组后24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of enrollment

Measure method:

指标中文名:

肾脏长度

指标类型:

次要指标

Outcome:

Renal length

Type:

Secondary indicator

测量时间点:

入组后24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of enrollment

Measure method:

指标中文名:

距离皮肤深度

指标类型:

次要指标

Outcome:

Depth to skin

Type:

Secondary indicator

测量时间点:

入组后24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of enrollment

Measure method:

指标中文名:

肾脏小叶间动脉阻力指数和流速

指标类型:

次要指标

Outcome:

Renal interlobular artery resistance index and flow rate

Type:

Secondary indicator

测量时间点:

入组后24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of enrollment

Measure method:

指标中文名:

尿素氮

指标类型:

次要指标

Outcome:

Cr

Type:

Secondary indicator

测量时间点:

入组后24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of enrollment

Measure method:

指标中文名:

肌酐

指标类型:

次要指标

Outcome:

Bun

Type:

Secondary indicator

测量时间点:

入组后24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of enrollment

Measure method:

指标中文名:

肾脏宽度

指标类型:

次要指标

Outcome:

Kidney width

Type:

Secondary indicator

测量时间点:

入组后24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of enrollment

Measure method:

指标中文名:

肾脏厚度

指标类型:

次要指标

Outcome:

Kidney thickness

Type:

Secondary indicator

测量时间点:

入组后24小时内 t

测量方法:

Measure time point of outcome:

Within 24 hours of enrollmen

Measure method:

指标中文名:

中极皮质剪切模量值

指标类型:

主要指标

Outcome:

Middle pole cortex shear modulus

Type:

Primary indicator

测量时间点:

入组后24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of enrollment

Measure method:

指标中文名:

下极皮质剪切模量值

指标类型:

主要指标

Outcome:

Lower pole cortex shear modulus

Type:

Primary indicator

测量时间点:

入组后24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of enrollment

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

非随机研究,采用连续入组方法

Randomization Procedure (please state who generates the random number sequence and by what method):

Non-randomized study, continuous enrollment method was used

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

试验完成6个月后通过咨询通讯作者后从百度云网盘获取

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Six months after the completion of the experiment, the data was obtained from Baidu cloud disk after consulting the corresponding author

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

ResMan

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

ResMan

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-07-01 17:29:18